|Articles|March 16, 2021
- Pharmaceutical Technology-03-15-2021
- Volume 2021 eBook
- Issue 1
Enabling the Virtual Human Through Physiologically-based Pharmacokinetic Modeling
Basic principles of physiologically-based pharmacokinetic (PBPK) modeling and its impact in streamlining the drug development process are reviewed.
Advertisement
Predictive sciences—built on improved computational capabilities and a deeper understanding of human physiology—are allowing researchers to perform human studies prior to, and sometimes in place of, human clinical trials in order to predict drug outcomes. Representatives of the
Article Details
Pharmaceutical Technology
eBook: Regulatory Sourcebook
March 2021
Pages: 24–27
Citation
When referring to this article, please cite it as H. Einolf ,et al., " Enabling the Virtual Human Through Physiologically-based Pharmacokinetic Modeling," Pharmaceutical Technology Regulatory Sourcebook eBook (March 2021).
Articles in this issue
over 4 years ago
It Takes a Bio/Pharma Villageover 4 years ago
Managing the Risk of Nitrosamine Impuritiesover 4 years ago
Collaborative Efforts Address Key Data Integrity Challengesover 4 years ago
Can FDA Reinvent Inspectionsover 4 years ago
FDA 2021 Guidance Agenda Sees Focus on Genericsover 4 years ago
A Real-World Approach to Evaluating Cleanroom Garmentsover 4 years ago
Resources, Guidelines, and Guidance Documents Directoryover 4 years ago
Regulatory and Standard Setting Organizations DirectoryNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
